Research Analysts Set Expectations for Enhabit, Inc.'s FY2025 … – MarketBeat


Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:

→ Defy New Year Volatility with Artificial Intelligence (From Vantage Point)document.write(‘pixel‘);pixel
Enhabit, Inc. (NYSE:EHABGet Rating) – Equities research analysts at Oppenheimer issued their FY2025 earnings per share (EPS) estimates for shares of Enhabit in a note issued to investors on Thursday, January 19th. Oppenheimer analyst M. Wiederhorn anticipates that the company will post earnings per share of $1.51 for the year. Oppenheimer has a “Market Perform” rating on the stock. The consensus estimate for Enhabit’s current full-year earnings is $1.45 per share.
Other analysts also recently issued research reports about the company. Stifel Nicolaus initiated coverage on Enhabit in a research report on Monday, December 5th. They issued a “buy” rating and a $17.00 target price for the company. CJS Securities started coverage on shares of Enhabit in a research note on Tuesday, December 13th. They issued a “market perform” rating and a $18.00 price objective for the company. Credit Suisse Group decreased their target price on shares of Enhabit from $19.00 to $15.00 and set a “neutral” rating on the stock in a research report on Friday, November 4th. Finally, UBS Group began coverage on Enhabit in a research note on Thursday, December 8th. They set a “sell” rating and a $12.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Enhabit presently has an average rating of “Hold” and a consensus price target of $16.43.

Enhabit Trading Up 4.9 %

EHAB opened at $15.00 on Friday. The business’s fifty day moving average price is $13.38. Enhabit has a twelve month low of $11.65 and a twelve month high of $25.25. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.63.
Enhabit (NYSE:EHABGet Rating) last posted its quarterly earnings data on Tuesday, November 1st. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.09). Enhabit had a return on equity of 7.62% and a net margin of 7.76%. The company had revenue of $265.70 million during the quarter, compared to analyst estimates of $265.62 million.

Insiders Place Their Bets

In other Enhabit news, Director Gregory S. Rush bought 8,300 shares of the firm’s stock in a transaction that occurred on Monday, November 7th. The stock was bought at an average price of $12.69 per share, for a total transaction of $105,327.00. Following the completion of the acquisition, the director now directly owns 16,597 shares in the company, valued at $210,615.93. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Gregory S. Rush bought 8,300 shares of the firm’s stock in a transaction dated Monday, November 7th. The stock was purchased at an average price of $12.69 per share, with a total value of $105,327.00. Following the transaction, the director now owns 16,597 shares of the company’s stock, valued at $210,615.93. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Jeffrey Bolton bought 2,000 shares of the stock in a transaction dated Wednesday, November 9th. The stock was purchased at an average price of $12.75 per share, with a total value of $25,500.00. Following the purchase, the director now owns 14,597 shares in the company, valued at $186,111.75. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 13,000 shares of company stock worth $164,903.

Institutional Investors Weigh In On Enhabit

Several hedge funds have recently bought and sold shares of EHAB. IFP Advisors Inc purchased a new position in shares of Enhabit during the third quarter valued at approximately $39,000. CI Investments Inc. purchased a new stake in Enhabit during the 2nd quarter valued at $27,000. Bessemer Group Inc. bought a new stake in shares of Enhabit in the 3rd quarter worth $26,000. Lazard Asset Management LLC purchased a new position in shares of Enhabit in the third quarter worth $34,000. Finally, South Dakota Investment Council purchased a new stake in shares of Enhabit during the third quarter valued at $45,000. Institutional investors own 95.55% of the company’s stock.

About Enhabit

(Get Rating)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Enhabit, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Enhabit wasn’t on the list.
While Enhabit currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat’s analysts have just released their top five short plays for February 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
If a company’s CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
[email protected]
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2023. All rights reserved.
© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.

source


Leave a Reply

Your email address will not be published.